Cargando…

An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic—Based on Cases of Dominant Listed Companies

The health insurance industry in China is undergoing great shocks and profound impacts induced by the worldwide COVID-19 pandemic. Taking for instance the three dominant listed companies, namely, China Life Insurance, Ping An Insurance, and Pacific Insurance, this paper investigates the equity perfo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Rendao, An, Na, Xie, Yichen, Luo, Kun, Lin, Ya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141801/
https://www.ncbi.nlm.nih.gov/pubmed/34041217
http://dx.doi.org/10.3389/fpubh.2021.663189
_version_ 1783696442735460352
author Ye, Rendao
An, Na
Xie, Yichen
Luo, Kun
Lin, Ya
author_facet Ye, Rendao
An, Na
Xie, Yichen
Luo, Kun
Lin, Ya
author_sort Ye, Rendao
collection PubMed
description The health insurance industry in China is undergoing great shocks and profound impacts induced by the worldwide COVID-19 pandemic. Taking for instance the three dominant listed companies, namely, China Life Insurance, Ping An Insurance, and Pacific Insurance, this paper investigates the equity performances of China's health insurance companies during the pandemic. We firstly construct a stock price forecasting methodology using the autoregressive integrated moving average, back propagation neural network, and long short-term memory (LSTM) neural network models. We then empirically study the stock price performances of the three listed companies and find out that the LSTM model does better than the other two based on the criteria of mean absolute error and mean square error. Finally, the above-mentioned models are used to predict the stock price performances of the three companies.
format Online
Article
Text
id pubmed-8141801
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81418012021-05-25 An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic—Based on Cases of Dominant Listed Companies Ye, Rendao An, Na Xie, Yichen Luo, Kun Lin, Ya Front Public Health Public Health The health insurance industry in China is undergoing great shocks and profound impacts induced by the worldwide COVID-19 pandemic. Taking for instance the three dominant listed companies, namely, China Life Insurance, Ping An Insurance, and Pacific Insurance, this paper investigates the equity performances of China's health insurance companies during the pandemic. We firstly construct a stock price forecasting methodology using the autoregressive integrated moving average, back propagation neural network, and long short-term memory (LSTM) neural network models. We then empirically study the stock price performances of the three listed companies and find out that the LSTM model does better than the other two based on the criteria of mean absolute error and mean square error. Finally, the above-mentioned models are used to predict the stock price performances of the three companies. Frontiers Media S.A. 2021-05-10 /pmc/articles/PMC8141801/ /pubmed/34041217 http://dx.doi.org/10.3389/fpubh.2021.663189 Text en Copyright © 2021 Ye, An, Xie, Luo and Lin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Ye, Rendao
An, Na
Xie, Yichen
Luo, Kun
Lin, Ya
An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic—Based on Cases of Dominant Listed Companies
title An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic—Based on Cases of Dominant Listed Companies
title_full An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic—Based on Cases of Dominant Listed Companies
title_fullStr An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic—Based on Cases of Dominant Listed Companies
title_full_unstemmed An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic—Based on Cases of Dominant Listed Companies
title_short An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic—Based on Cases of Dominant Listed Companies
title_sort empirical study on the equity performance of china's health insurance companies during the covid-19 pandemic—based on cases of dominant listed companies
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141801/
https://www.ncbi.nlm.nih.gov/pubmed/34041217
http://dx.doi.org/10.3389/fpubh.2021.663189
work_keys_str_mv AT yerendao anempiricalstudyontheequityperformanceofchinashealthinsurancecompaniesduringthecovid19pandemicbasedoncasesofdominantlistedcompanies
AT anna anempiricalstudyontheequityperformanceofchinashealthinsurancecompaniesduringthecovid19pandemicbasedoncasesofdominantlistedcompanies
AT xieyichen anempiricalstudyontheequityperformanceofchinashealthinsurancecompaniesduringthecovid19pandemicbasedoncasesofdominantlistedcompanies
AT luokun anempiricalstudyontheequityperformanceofchinashealthinsurancecompaniesduringthecovid19pandemicbasedoncasesofdominantlistedcompanies
AT linya anempiricalstudyontheequityperformanceofchinashealthinsurancecompaniesduringthecovid19pandemicbasedoncasesofdominantlistedcompanies
AT yerendao empiricalstudyontheequityperformanceofchinashealthinsurancecompaniesduringthecovid19pandemicbasedoncasesofdominantlistedcompanies
AT anna empiricalstudyontheequityperformanceofchinashealthinsurancecompaniesduringthecovid19pandemicbasedoncasesofdominantlistedcompanies
AT xieyichen empiricalstudyontheequityperformanceofchinashealthinsurancecompaniesduringthecovid19pandemicbasedoncasesofdominantlistedcompanies
AT luokun empiricalstudyontheequityperformanceofchinashealthinsurancecompaniesduringthecovid19pandemicbasedoncasesofdominantlistedcompanies
AT linya empiricalstudyontheequityperformanceofchinashealthinsurancecompaniesduringthecovid19pandemicbasedoncasesofdominantlistedcompanies